Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model

Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model

<p>Abstract</p> <p>Background</p> <p>Interferon-γ-inducible protein 10 (IP-10) is a potent inhibitor of tumor angiogenesis. It has been reported that the antiangiogenic therapy combined with chemotherapy has synergistic effects.</p> <p>Methods</p> <...

Full description

Bibliographic Details
Main Authors:	Zhang Zhixuan, Yu Jingrui, Tian Ling, Wang Lian, Mei Kai, Wei Yuquan
Format:	Article
Language:	English
Published:	BMC 2008-11-01
Series:	Journal of Experimental & Clinical Cancer Research
Online Access:	http://www.jeccr.com/content/27/1/63

Similar Items

Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model
by: Zhengwen Xiao, et al.
Published: (2011-01-01)

Evasion of interferon-gamma responses by Toxoplasma gondii in murine and human fibroblasts
by: Roberts, Wendy Niedelman
Published: (2014)

Interferon-gamma mediates host resistance in a murine model of melioidosis.
by: Santanirand, P, et al.
Published: (1997)

Antitumor effect of recombinant interferon-gamma in an experimental model of Ehrlich’s bilateral solid carcinoma
by: V. G. Isaeva, et al.
Published: (2022-06-01)

Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
by: Yang Wang, et al.
Published: (2019-01-01)

ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models
by: Zachary S Morris, et al.
Published: (2023-09-01)

Interferon-Gamma-Mediated Osteoimmunology
by: Mengjia Tang, et al.
Published: (2018-06-01)

Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?
by: Mohammed Ahmed Yassin, et al.
Published: (2011-01-01)

Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma
by: Lu Liu, et al.
Published: (2022-12-01)

Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells
by: Immacolata Maietta, et al.
Published: (2022-07-01)

TL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI.
by: Chani Komar-Stossel, et al.
Published: (2014-01-01)

Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma
by: Li Y, et al.
Published: (2019-04-01)

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression
by: Guo ZY, et al.
Published: (2018-08-01)

Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei.
by: Santanirand, P, et al.
Published: (1999)

Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma.
by: Williams, R, et al.
Published: (1993)

Interferon-Gamma-Induced Nitric Oxide Inhibits the Proliferation of Murine Renal Cell Carcinoma Cells
by: David J. Tate Jr., John R. Patterson, Cruz Velasco-Gonzalez, Emily N. Carroll, Janie Trinh, Daniel Edwards, Ashok Aiyar, Beatriz Finkel-Jimenez, Arnold H. Zea
Published: (2012-01-01)

Interferon gamma and sonic hedgehog signaling are required to dysregulate murine neural stem/precursor cells.
by: Janine Walter, et al.
Published: (2012-01-01)

429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment
by: Leila Takahashi-Ruiz, et al.
Published: (2023-04-01)

Interferon gamma-induced protein 10 (IP-10) and cardiovascular disease in African Americans.
by: Colton Leavitt, et al.
Published: (2020-01-01)

Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01)

Efficacy and safety of albumin-bound paclitaxel combined with gemcitabine in the treatment of advanced and metastatic pancreatic cancer
by: TIAN Yue, et al.
Published: (2023-09-01)

Interferon gamma: friend or foe?
by: Wood, K, et al.
Published: (2007)

Gamma interferon supplementation for melioidosis.
by: Koh, G, et al.
Published: (2010)

Interferon-Gamma: Treatment Horizons
by: A. A. Khryanin, et al.
Published: (2020-05-01)

Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection.
by: Silvia Gimeno Brias, et al.
Published: (2018-01-01)

The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis.
by: Lauw, F, et al.
Published: (2000)

Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro
by: Lei Kong, et al.
Published: (2022-05-01)

Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies
by: Lutz, Emi A, et al.
Published: (2023)

Interferón-gamma e interleucina-10 sérica en niños anémicos con deficiencia de vitamina A Serum levels of interferon-gamma and interleukine- 10 in anemic children with vitamin A deficiency.
by: Jorymar Y Leal, et al.
Published: (2006-12-01)

CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer
by: Fei Geng, et al.
Published: (2022-09-01)

In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the treatment of nasopharyngeal carcinoma
by: Xue C, et al.
Published: (2016-03-01)

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers
by: Rathos Maggie J, et al.
Published: (2012-08-01)

Differential expression of interferon-gamma and interferon-gamma-inducing cytokines in Thai patients with scrub typhus or leptospirosis.
by: Chierakul, W, et al.
Published: (2004)

Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy
by: Wang D, et al.
Published: (2024-12-01)

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine
by: Sophie Voruz, et al.
Published: (2021-05-01)

Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.
by: Véronique Corbière, et al.
Published: (2012-01-01)

Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8+ T Cells
by: Duo Chen, et al.
Published: (2021-02-01)

The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response
by: Niedelman, Wendy Leah, et al.
Published: (2012)

P18 surface antigen mediates reactivation of cerebral toxoplasmosis in murine models displaying an interferon-gamma immune response
by: Maguy Hamie, et al.
Published: (2020-12-01)

The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response.
by: Wendy Niedelman, et al.
Published: (2012-01-01)